Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.89% | 33.74% | -22.26% | -1.57% | 1.52% |
| Total Depreciation and Amortization | 12.18% | -5.17% | -20.59% | 20.43% | 78.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.00% | -253.93% | 437.68% | -21.83% | 122.77% |
| Change in Net Operating Assets | -260.71% | 508.64% | -207.42% | 133.27% | -211.84% |
| Cash from Operations | 211.41% | -83.56% | 16.42% | 77.84% | 98.44% |
| Capital Expenditure | 39.54% | -34.56% | 4.28% | -17.79% | 17.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.44% | -1,305.70% | -548.07% | -94.02% | 15.13% |
| Cash from Investing | 73.05% | -176.17% | -11.49% | -156.97% | 93.53% |
| Total Debt Issued | -47.82% | 4,194.53% | -98.42% | 65.31% | -38.87% |
| Total Debt Repaid | -6.85% | -0.61% | 98.23% | -439.04% | -2,678.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 81.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -203.21% | -- |
| Cash from Financing | -158.28% | 271.50% | 61.92% | -1,179.51% | -87.63% |
| Foreign Exchange rate Adjustments | -356.51% | 67.42% | 108.01% | -915.65% | -111.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.45% | -140.97% | 168.55% | -194.96% | 155.56% |